Relmada Therapeutics annual revenue
2012
2013
Relmada Therapeutics Revenue Growth & History (RLMD)
Relmada Therapeutics reported $5,129 in revenue for fiscal 2013, a decrease of 35.41% from the previous fiscal year.
View full Relmada Therapeutics company overviewRelmada Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2013 | 2013-08-31 | $5,129 | −$2,812 | −35.41% |
| 2012 · Aug 31 | 2012-08-31 | $7,941 | — | — |
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Primary source
SEC company filings
TickerStat standardizes reported company facts from SEC EDGAR. Derived growth rates use the displayed revenue values and are not company guidance or forecasts.
Review Relmada Therapeutics filings at SEC.gov ↗